Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

66 ta ish

Ish: Involving stemness factors to improve CAR T-cell-based cancer immunotherapy

  1. NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma

    Tobias Weiß, Michael Weller, Matthias Gückenberger +2

    Maqola20173 iqtibos
    ABI

  2. Neurokinin-1 Receptor (NK-1R) Antagonists: Potential Targets in the Treatment of Glioblastoma Multiforme

    Amir R. Afshari, Ali Motamed‐Sanaye, Hamed Sabri +7

    Maqola20213 iqtibos
    ABI

  3. Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines

    Edmund K. Moon, Liang‐Chuan S. Wang, Kheng Bekdache +4

    Maqola20172 iqtibos
    ABI

  4. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity

    Zong Sheng Guo, Zuqiang Liu, David L. Bartlett

    Sharh maqola20142 iqtibos
    ABI

  5. Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies

    Shashi Gujar, Jonathan Pol, Youra Kim +2

    Sharh maqola20172 iqtibos
    ABI

  6. c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target

    Chenwei Li, Jingjiang Wu, Mark J. Hynes +5

    Maqola20112 iqtibos
    ABI

  7. The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

    Markus Münz, Patrick A. Baeuerle, Olivier Gires

    Sharh maqola20092 iqtibos
    ABI

  8. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells

    Amélie Montel‐Hagen, Christopher S. Seet, Suwen Li +11

    Maqola20192 iqtibos
    ABI

  9. Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

    Esther Drent, Renée Poels, Ruud Ruiter +9

    Maqola20192 iqtibos
    ABI

  10. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

    Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai +17

    Maqola20212 iqtibos
    ABI

  11. Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy

    Ramazan Rezaei, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour +5

    Sharh maqola20212 iqtibos
    ABI

  12. Merkel cell carcinoma on the right calf in association with chronic lymphocytic leukemia: A case report

    Hamideh Mohammadzadeh, Sepideh Babaniamansour, Mohammadreza Majidi +3

    Maqola20212 iqtibos
    ABI

  13. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer

    Alireza Azani, Sima Parvizi Omran, Haniyeh Ghasrsaz +14

    Sharh maqola20232 iqtibos
    ABI

  14. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI